This effect was particularly evident in patients with concomitant atrial fibrillation.27 Another prospective study involving 362 AIS-LVO patients undergoing EVT identified admission high-sensitivity CRP (hs-CRP) levels above 8.255 mg/L were significantly associated with worse 90-day clinical outcomes.28 However, in the analysis observing long-term outcomes, this study did not clearly exclude patients with infections or other serious complications, which may affect the accuracy of results. The gene discussed is CRP; the disease is atrial fibrillation.